Leslie Kurtzberg

930 total citations
14 papers, 780 citations indexed

About

Leslie Kurtzberg is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Leslie Kurtzberg has authored 14 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Nephrology. Recurrent topics in Leslie Kurtzberg's work include Cancer therapeutics and mechanisms (4 papers), TGF-β signaling in diseases (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Leslie Kurtzberg is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), TGF-β signaling in diseases (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Leslie Kurtzberg collaborates with scholars based in United States, Canada and Hungary. Leslie Kurtzberg's co-authors include John M. Wozney, Vicki Rosen, B. A. Ashton, R. Scott Thies, Rebecca G. Bagley, Beverly A. Teicher, Cécile Rouleau, Steven Ledbetter, Bruce M. Pratt and Min Yao and has published in prestigious journals such as Clinical Cancer Research, Endocrinology and Kidney International.

In The Last Decade

Leslie Kurtzberg

13 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Kurtzberg United States 11 437 185 149 130 119 14 780
Chaoxiang Shui United States 7 444 1.0× 115 0.6× 232 1.6× 81 0.6× 104 0.9× 10 785
Pierre Guihard France 12 422 1.0× 218 1.2× 189 1.3× 149 1.1× 152 1.3× 24 1.0k
Elaine Langenfeld United States 9 572 1.3× 83 0.4× 206 1.4× 113 0.9× 58 0.5× 11 745
Kimberly A. Jacobsen United States 6 393 0.9× 132 0.7× 171 1.1× 93 0.7× 184 1.5× 7 884
Fina Liu Canada 8 343 0.8× 214 1.2× 139 0.9× 175 1.3× 80 0.7× 9 644
Keigo Hanada Japan 8 294 0.7× 223 1.2× 121 0.8× 161 1.2× 154 1.3× 13 819
Bénédicte Brounais France 7 347 0.8× 152 0.8× 223 1.5× 84 0.6× 97 0.8× 11 714
Guiti Z. Eghbali-Fatourechi United States 7 310 0.7× 80 0.4× 190 1.3× 100 0.8× 145 1.2× 7 719
Krishna M. Sinha United States 13 736 1.7× 88 0.5× 163 1.1× 110 0.8× 66 0.6× 26 1.0k
Naito Kurio Japan 18 429 1.0× 84 0.5× 161 1.1× 139 1.1× 67 0.6× 39 739

Countries citing papers authored by Leslie Kurtzberg

Since Specialization
Citations

This map shows the geographic impact of Leslie Kurtzberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Kurtzberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Kurtzberg more than expected).

Fields of papers citing papers by Leslie Kurtzberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Kurtzberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Kurtzberg. The network helps show where Leslie Kurtzberg may publish in the future.

Co-authorship network of co-authors of Leslie Kurtzberg

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Kurtzberg. A scholar is included among the top collaborators of Leslie Kurtzberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Kurtzberg. Leslie Kurtzberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bagley, Rebecca G., Leslie Kurtzberg, William Weber, et al.. (2011). sFLT01: A Novel Fusion Protein with Antiangiogenic Activity. Molecular Cancer Therapeutics. 10(3). 404–415. 20 indexed citations
2.
Teicher, Beverly A., et al.. (2011). Characteristics of Human Ewing/PNET Sarcoma Models. Annals of Saudi Medicine. 31(2). 174–182. 2 indexed citations
3.
Bagley, Rebecca G., Leslie Kurtzberg, Cécile Rouleau, Min Yao, & Beverly A. Teicher. (2011). Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells. Cancer Chemotherapy and Pharmacology. 68(6). 1537–1546. 30 indexed citations
4.
Bagley, Rebecca G., Yi Ren, William Weber, et al.. (2011). Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy. Clinical Cancer Research. 17(5). 976–988. 49 indexed citations
5.
Teicher, Beverly A., et al.. (2011). Characteristics of human Ewing/PNET sarcoma models. Annals of Saudi Medicine. 31(2). 174–182. 26 indexed citations
6.
Kurtzberg, Leslie, Stephanie Roth, Min Yao, et al.. (2011). Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment. Clinical Cancer Research. 17(9). 2777–2787. 40 indexed citations
7.
Kurtzberg, Leslie, Stephanie Roth, Rebecca G. Bagley, et al.. (2009). Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents. Cancer Chemotherapy and Pharmacology. 64(5). 1029–1038. 4 indexed citations
8.
Rouleau, Cécile, William Weber, Robert Smale, et al.. (2008). Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma. Clinical Cancer Research. 14(22). 7223–7236. 86 indexed citations
9.
Kurtzberg, Leslie, Traci E. Battle, Cécile Rouleau, et al.. (2008). Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics. 7(10). 3212–3222. 30 indexed citations
10.
Ledbetter, Steven, Leslie Kurtzberg, Susan E. Doyle, & Bruce M. Pratt. (2000). Renal fibrosis in mice treated with human recombinant transforming growth factor-β2. Kidney International. 58(6). 2367–2376. 54 indexed citations
11.
Kelly, Francis J., Sharon Anderson, T Oyama, et al.. (1999). Acute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat. Journal of the American Society of Nephrology. 10(6). 1264–1273. 30 indexed citations
12.
13.
Thies, R. Scott, et al.. (1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells.. Endocrinology. 130(3). 1318–1324. 355 indexed citations
14.
Rosen, Vicki, et al.. (1989). Purification and Molecular Cloning of a Novel Group of Bmps and Localization of Bmp Mrna in Developing Bone. Connective Tissue Research. 20(1-4). 313–319. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaoxiang Shui Breakdown of academic impact, for papers by Pierre Guihard Breakdown of academic impact, for papers by Elaine Langenfeld Breakdown of academic impact, for papers by Kimberly A. Jacobsen Breakdown of academic impact, for papers by Fina Liu Breakdown of academic impact, for papers by Keigo Hanada Breakdown of academic impact, for papers by Bénédicte Brounais Breakdown of academic impact, for papers by Guiti Z. Eghbali-Fatourechi Breakdown of academic impact, for papers by Krishna M. Sinha Breakdown of academic impact, for papers by Naito Kurio
Rankless by CCL
2026